Application of artesunate in preparation of drug for inhibiting tumor cell drug resistance
A tumor cell and artesunate technology, applied in the field of biomedicine, can solve problems such as unclear mechanism and damage, and achieve good cytotoxicity and induce cell apoptosis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] Example 1 Effect of artesunate on tumor cell lysosome function
[0029] 1.1 Materials and methods
[0030] 1) Experimental materials
[0031]
[0032] 2) Experimental cells
[0033] Human breast cancer MCF-7 cells were purchased from the cell bank of the Institute of Cell Biology, Chinese Academy of Sciences and preserved in our laboratory; human cervical cancer Hela cells were purchased from the cell bank of the Institute of Cell Biology of the Chinese Academy of Sciences and preserved in our laboratory; human colon cancer HCT116 Cells were purchased from the Cell Bank of the Institute of Cell Biology, Chinese Academy of Sciences and preserved in our laboratory; human liver cancer HepG2 cells were purchased from the Cell Bank of the Institute of Cell Biology of the Chinese Academy of Sciences and preserved in our laboratory; human lung cancer A549 cells were purchased from the Cell Biology of the Chinese Academy of Sciences The cell bank of the research institute ...
Embodiment 2
[0046] Example 2 Relationship between lysosome function and drug resistance
[0047] 2.1 Effect of lysosomal synthesis-related transcription factor TFEB on the efficacy of cytotoxic drugs
[0048] TFEB is the main gene that regulates lysosomal biosynthesis, and can improve autophagy / lysosomal function by regulating the expression of autophagy / lysosomal biosynthesis-related genes. Therefore, we enhanced or weakened the function of lysosomes by up-regulating or down-regulating the level of TFEB, and further explored the effect of artesunate on cells.
[0049] 2.1.1 Materials and methods
[0050] 1) Experimental materials
[0051]
[0052] 2) Lentivirus
[0053] TFEB overexpression lentivirus and mutant lentivirus were constructed by Jikai Company: LV-TFEB (6778-1), (titer 1E+8TU / mL); negative control virus CON195 (Ubi-MCS-3FLAG-SV40-puromysin) , (titer is 1E+9TU / mL).
[0054] 3) siRNA
[0055] TFEB siRNAsense: 5'-GAGACGAAGGTTCAACATCAA-3'.
[0056] 2.1.2. Method and st...
Embodiment 3
[0070] Example 3 Comparison of lysosome functions in several drug-resistant cells
[0071] 3.1 Materials
[0072]
[0073] Human breast cancer cell MCF-7 / ADR resistant to doxorubicin was purchased from the cell bank of the Institute of Cell Biology, Chinese Academy of Sciences and preserved in our laboratory; human lung cancer cell A549 / TAX resistant to paclitaxel was donated by teacher Liang Zhongqin’s laboratory at Soochow University; human lung cancer The cisplatin-resistant cell A549 / DDP was donated by the laboratory of Mr. Liang Zhongqin of Soochow University.
[0074] 3.2 Methods and steps
[0075] 1) MCF-7 / ADR resistance maintenance
[0076] During the cell culture process, doxorubicin was added for maintenance, and the concentration of doxorubicin was increased by 0.01 μg / mL for each passage, depending on the state of the cells in the middle, and finally added to 2 μg / mL.
[0077] 2) A549 / DDP resistance maintenance
[0078] During the cell culture process, cispl...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com